Investors had “incredibly high” expectations around the Phase 3 data for the drugmaker’s experimental cancer treatment.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。
Veytics Intelligence
The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
